Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28966751 | 0.95 | TRPV4 (0.31) | TRPV4 | |
| SCHEMBL30165352 | 0.95 | TRPV4 (0.31) | TRPV4 | |
| SCHEMBL22579155 | 0.92 | TRPV4 (0.30) | TRPV4 | |
| SCHEMBL8346781 | 0.92 | TRPV4 (0.32) | TRPV4ATM | |
| SCHEMBL5334905 | 0.89 | TRPV4 (0.31) | TRPV4 | |
| SCHEMBL20596085 | 0.88 | TRPV4 (0.33) | TRPV4ATM | |
| SCHEMBL5333617 | 0.88 | TRPV4 (0.33) | TRPV4ATM | |
| SCHEMBL20521848 | 0.86 | TRPV4 (0.32) | TRPV4ATM | |
| SCHEMBL28966761 | 0.86 | TRPV4 (0.32) | TRPV4ATM | |
| SCHEMBL57543 | 0.84 | TRPV4 (0.41) | TRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115745974-A | Chiral near ultraviolet organic electroluminescent material, preparation method thereof and application thereof in CP-OLED | 华南理工大学 | 2023-03-07 | — | — | CN | claimed |
| US-20260047341-A1 | COMPOUND, LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING ELEMENT | KYULUX INC (JP) | 2026-02-12 | — | — | US | disclosed |
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2025-07-22 | — | — | US | disclosed |
| CN-112786795-B | Organic electroluminescent device and aromatic compound for organic electroluminescent device | 三星显示有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-119965341-A | Electrolyte and battery | 珠海冠宇电池股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20250120247-A1 | LIGHT EMITTING ELEMENT, POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-04-10 | — | — | US | disclosed |
| CN-119775282-A | Light emitting element, polycyclic compound for light emitting element, and display device including light emitting element | 三星显示有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-112585778-B | Organic light-emitting element, composition, and film | 国立大学法人九州大学 | 2025-04-04 | — | — | CN | disclosed |
| EP-3587399-B1 | COMPOUND, LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING ELEMENT | KYULUX INC (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-20070161626-A1 | Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof | AVENTIS PHARMA S.A. (FR) | 2007-07-12 | — | — | US | disclosed |
| EP-1765813-A1 | SUBSTITUTED INDAZOLES, COMPOSITIONS CONTAINING SAME, PREPARATION AND USE | Aventis Pharma S.A. (FR) | 2007-03-28 | — | — | EP | disclosed |
| US-20060211739-A1 | Use of selective P2X7 receptor antagonists | ABBOTT LABORATORIES | 2006-09-21 | — | — | US | disclosed |
| WO-2006086229-A1 | THE USE OF SELECTIVE P2X7 RECEPTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006003276-A1 | SUBSTITUTED INDAZOLES, COMPOSITIONS CONTAINING SAME, PREPARATION AND USE | AVENTIS PHARMA S.A. (FR) | 2006-01-12 | — | — | WO | disclosed |
| US-6949579-B2 | Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof | AVENTIS PHARMA S.A. (FR) | 2005-09-27 | — | — | US | disclosed |
| EP-1487804-A2 | AMINOINDAZOLE DERIVATIVES AS PROTEIN-KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2004-12-22 | — | — | EP | disclosed |
| US-20040014802-A1 | Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof | AVENTIS PHARMA S.A. (FR) | 2004-01-22 | — | — | US | disclosed |
| WO-2003078403-A2 | DERIVES D’AMINOINDAZOLES COMME INHIBITEURS DE PROTEINE-KINASE | AVENTIS PHARMA S.A. (FR) | 2003-09-25 | — | — | WO | disclosed |
| US-5622137-A | FOR USE IN TESTING COOKED FOODS | TRANS WORLD SERVICES (US) | 1997-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014802-A1 | Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof | CYP2C8, NR0B2, NR2C2 | TRPV4 4168/4885ATM 3307/4885 |
| US-20070161626-A1 | Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof | CYP3A43, CYP3A7, CYP3A5 | TRPV4 4396/4885ATM 1847/4885 |
| US-20260047341-A1 | COMPOUND, LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING ELEMENT | LBR, CTNND1, IK | TRPV4 385/4885ATM 4119/4885 |
| US-20060211739-A1 | Use of selective P2X7 receptor antagonists | P2RX1, P2RX3, P2RX7 | TRPV4 92/4885ATM 4381/4885 |
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | TRPV4 227/4885ATM 1817/4885 |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | TRPV4 227/4885ATM 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.